Global  

Coronavirus Vaccine Shows Promising Early Results in China

NYTimes.com Friday, 22 May 2020 ()
A trial with 108 participants suggests the vaccine is safe and may be moderately effective. But experts noted that the approach has failed in the past.
0
shares
ShareTweetSavePostSend
 
Credit: Wochit - Published
News video: Dr. Fauci Is 'Cautiously Optimistic' About Possibility Of COVID-19 Vaccine

Dr. Fauci Is 'Cautiously Optimistic' About Possibility Of COVID-19 Vaccine 00:32

Researchers working on a vaccine for the novel coronavirus have announced promising results in a very small drug trial. Biotech company Moderna said the first phase of trials for a COVID-19 vaccine was tested on 45 human volunteers. Early data shows eight of the volunteers developed a type of...

Related videos from verified sources

Coronavirus Vaccine From China Is Safe In Early Trial [Video]

Coronavirus Vaccine From China Is Safe In Early Trial

A coronavirus vaccine developed by CanSino Biologics Inc appears to be safe. It induced a rapid immune response in its first human trial, Reuters reports. This vaccine did not cause any serious adverse..

Credit: Wochit Business     Duration: 00:39Published
AstraZeneca to make billion COVID vaccine doses if tests succeed [Video]

AstraZeneca to make billion COVID vaccine doses if tests succeed

AstraZeneca expects to be able to deliver a billion doses of a possible COVID-19 vaccine this year and next if tests are successful, adding on Thursday it should shortly get results of an early stage..

Credit: Reuters Studio     Duration: 01:20Published

You Might Like


Tweets about this